Adage Capital Partners Gp, L.L.C. Abb Vie Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

$54.6 Billion
Q3 2024

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Abb Vie Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,657,783 shares of ABBV stock, worth $301 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

1,657,783

Previous 1,420,280 16.72%

Holding current value

$301 Million

Previous $244 Million 34.39%

% of portfolio

0.6%

Previous 0.47%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $38.9 Million - $47.3 Million	237,503 Added 16.72%	1,657,783 $327 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $153 Million - $178 Million	-986,865 Reduced 41.0%	1,420,280 $244 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $4.46 Million - $5.08 Million	27,904 Added 1.17%	2,407,145 $438 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $50.1 Million - $56.5 Million	364,424 Added 18.09%	2,379,241 $369 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $66.7 Million - $77.2 Million	498,978 Added 32.92%	2,014,817 $300 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $61.8 Million - $76.9 Million	466,069 Added 44.4%	1,515,839 $204 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $20.4 Million - $23.5 Million	-141,253 Reduced 11.86%	1,049,770 $167 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $78 Million - $93.5 Million	-563,623 Reduced 32.12%	1,191,023 $193 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $18.9 Million - $21.6 Million	140,475 Added 8.7%	1,754,646 $235 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $83.5 Million - $106 Million	-606,900 Reduced 27.32%	1,614,171 $247 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $31.3 Million - $38.8 Million	237,200 Added 11.96%	2,221,071 $360 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $57.3 Million - $72.5 Million	533,700 Added 36.8%	1,983,871 $269 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $72.9 Million - $82.8 Million	-685,440 Reduced 32.1%	1,450,171 $156 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $4.86 Million - $5.42 Million	-46,200 Reduced 2.12%	2,135,611 $241 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $19.1 Million - $21 Million	-186,800 Reduced 7.89%	2,181,811 $236 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $28.1 Million - $37.9 Million	-349,100 Reduced 12.85%	2,368,611 $254 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $59.7 Million - $70.1 Million	695,400 Added 34.39%	2,717,711 $238 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $148 Million - $199 Million	2,022,311 New	2,022,311 $199 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $74.8 Million - $93.6 Million	-1,037,161 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $22.9 Million - $27.6 Million	-364,201 Reduced 25.99%	1,037,161 $78.5 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $92.1 Million - $118 Million	1,401,362 New	1,401,362 $102 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $30 Million - $35.3 Million	-388,962 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $9.05 Million - $11.2 Million	-116,300 Reduced 23.02%	388,962 $35.9 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $45.5 Million - $50.5 Million	-511,400 Reduced 50.3%	505,262 $47.8 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $94.5 Million - $112 Million	-1,052,661 Reduced 50.87%	1,016,662 $94.2 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $9.25 Million - $12.4 Million	-100,545 Reduced 4.63%	2,069,323 $196 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $32.6 Million - $35.7 Million	-363,500 Reduced 14.35%	2,169,868 $210 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $177 Million - $226 Million	2,533,368	2,533,368 $225 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $321B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Abb Vie Inc. Transaction History